CSOP Hang Seng Biotech ETF (03174.HK) Rises 0.22% Intraday at HK$3.708
NewTimeSpace News: As of 13:46, September 2, 2026,CSOP Hang Seng Biotech ETF(03174.HK) climbed 0.22% to HK$3.708. The ETF traded 473,600 shares with a turnover of HK$1.7551 million. Its average traded price stood at HK$3.706, with a volume ratio of 0.45, turnover rate of 0.19% and amplitude of 1.68%. Its current net asset value per unit is HK$3.709, AUM amounts to HK$945 million, and each board lot is 100 shares.
CSOP Hang Seng Biotech ETF(03174.HK) tracks the Hang Seng Biotechnology Index. It focuses on leading biotech companies listed in Hong Kong, covering sectors including innovative pharmaceuticals, CXO, vaccines and gene therapy.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- HK shares ETFs Daily Report: Robotics and AI Lead HK ETFs! Hang Seng Biotech ETFs Plunge Over 3.7%, Biomedicine and Blockchain ETFs Collapse - 20260831
- CSOP Hang Seng Biotech ETF (03174.HK) Falls 3.99% in Afternoon Trade, Turnover at HKD 9.4078 Million
- CSOP Hang Seng Biotech ETF (03174.HK) Falls 0.92% in Morning Trade, Turnover at HKD 2.1838 Million
- CSOP Hang Seng Biotech ETF (03174.HK) Rises 0.67% in Morning Trade, AUM at HKD 988 Million
- CSOP Hang Seng Biotech ETF (03174.HK): Up 1.66% Intraday at HK$3.80